Search results for "Depression"
Depression risk lower with GLP-1 receptor agonists than DPP-4 inhibitors, target trial finds
Older patients with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists had a modestly decreased risk for incident depression compared with those on dipeptidyl peptidase-4 (DPP-4) inhibitors, but no difference was found compared to sodium-glucose cotransporter-2 inhibitors, according to the target trial emulation study.
https://immattersacp.org/weekly/archives/2025/02/25/1.htm
25 Feb 2025
Walking, jogging, yoga, and strength training help treat depression, analysis finds
More vigorous exercise had a greater effect on depression, according to a meta-analysis of 218 randomized controlled trials that examined the effect of exercise on major depressive disorder compared with psychotherapy, antidepressants, and control conditions.
https://immattersacp.org/weekly/archives/2024/02/20/1.htm
20 Feb 2024
Mobile apps can help treat moderate to severe depression
A meta-analysis found that the apps were effective regardless of whether patients were currently receiving depression treatment. Interventions that lasted less than eight weeks were more effective than longer ones.
https://immattersacp.org/weekly/archives/2023/11/28/2.htm
28 Nov 2023
ACP's updated depression guideline recommends CBT, second-generation antidepressants
ACP stressed the importance of informing patients and taking their preferences into account when deciding between the recommended first-line therapies of cognitive behavioral therapy (CBT) or an antidepressant.
https://immattersacp.org/weekly/archives/2023/01/24/1.htm
24 Jan 2023
Portal-based population health screening appears effective for depression
Patients who received emails inviting them to complete an online screener via a patient portal were more likely to be screened for depression and had a higher rate of positive screens than those who received usual care, a single-center study found.
https://immattersacp.org/weekly/archives/2022/09/27/2.htm
27 Sep 2022
Nondrug therapies outperformed drugs for depression symptoms in dementia, review finds
Massage and touch therapy, cognitive stimulation combined with a cholinesterase inhibitor, and cognitive stimulation combined with exercise and social interaction were more efficacious for symptoms of depression in people with dementia and without a diagnosis of a major depressive disorder.
https://immattersacp.org/weekly/archives/2021/03/30/4.htm
30 Mar 2021
Meta-analysis finds no association between beta-blocker therapy, depression
Beta-blockers did not appear to affect depression or other psychiatric adverse events, with the possible exception of sleep-related disorders, a recent study found.
https://immattersacp.org/weekly/archives/2021/03/23/5.htm
23 Mar 2021
Anti-inflammatory agents may effectively, safely curb major depressive symptoms, study finds
A pooled data analysis looked at depression treatment trials that compared NSAIDs, omega-3 fatty acids, cytokine inhibitors, statins, steroids, minocycline, modafinil, or N-acetylcysteine to placebo.
https://immattersacp.org/weekly/archives/2019/11/05/4.htm
5 Nov 2019
Study finds frequent use of medications for which depression is an adverse effect
Overall estimated prevalence of use of medications with depression as a potential adverse effect was 37.2%, increasing from 35.0% in 2005 and 2006 to 38.4% in 2013 and 2014.
https://immattersacp.org/weekly/archives/2018/06/19/2.htm
19 Jun 2018
Preventive cognitive therapy is an effective alternative and addition to antidepressants for preventing depression relapse, study finds
Maintenance treatment with antidepressants was not superior to preventive cognitive therapy after remission or recovery of major depressive disorder, but adding preventive cognitive therapy to antidepressant therapy was superior to antidepressant therapy alone.
https://immattersacp.org/weekly/archives/2018/04/10/2.htm
10 Apr 2018
ACP issues clinical practice guideline on depression treatment in adults
ACP recommends that clinicians choose between cognitive behavioral therapy or second-generation antidepressants to treat patients with major depressive disorder after discussing treatment effects, adverse effect profiles, cost, accessibility, and preferences with the patient.
https://immattersacp.org/weekly/archives/2016/02/09/1.htm
9 Feb 2016
Study finds one-third of medical residents screen positive for depression or its symptoms
Also, the prevalence of depression increased each year of the study.
https://immattersacp.org/weekly/archives/2015/12/15/1.htm
15 Dec 2015
USPSTF issues draft recommending screening for depression in all adults
Screening should be implemented with “adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate followup.”
https://immattersacp.org/weekly/archives/2015/08/04/2.htm
4 Aug 2015
Antidepressants work for patients with comorbidities
Patients with comorbidities can be safely and effectively treated for major depressive disorder (MDD) with antidepressants, even combination therapy, with no more adverse effects than their healthier counterparts, researchers concluded.
https://immattersacp.org/weekly/archives/2012/01/24/5.htm
24 Jan 2012